Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Patient selection for lung volume reduction surgery.

Fernando J Martinez1, Kevin R Flaherty, Mark D Iannettoni

  • 1Division of Pulmonary and Critical Care Medicine, University of Michigan Health System, 1500 E. Medical Center Drive, 3916 Taubman Center, Ann Arbor, MI 48109-0360, USA. fmartine@umich.edu

Chest Surgery Clinics of North America
|December 20, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Future concepts in bronchodilation for COPD: dual- <i>versus</i> monotherapy.

European respiratory review : an official journal of the European Respiratory Society·2021
Same author

Comparative Impact of Depressive Symptoms and FEV<sub>1</sub>% on Chronic Obstructive Pulmonary Disease.

Annals of the American Thoracic Society·2021
Same author

A single blood eosinophil count measurement is as good as two for prediction of ICS treatment response in the IMPACT trial.

The European respiratory journal·2021
Same author

Barriers to antigen detection and avoidance in chronic hypersensitivity pneumonitis in the United States.

Respiratory research·2021
Same author

Identifying organ dysfunction trajectory-based subphenotypes in critically ill patients with COVID-19.

Scientific reports·2021
Same author

Challenging the obesity paradox: extreme obesity and COPD mortality in the SUMMIT trial.

ERJ open research·2021
Same journal

New treatment modalities for end-stage emphysema.

Chest surgery clinics of North America·2003
Same journal

Cost effectiveness of lung volume reduction surgery.

Chest surgery clinics of North America·2003
Same journal

Results of lung volume reduction surgery for emphysema.

Chest surgery clinics of North America·2003
Same journal

Complications after lung volume reduction surgery.

Chest surgery clinics of North America·2003
Same journal

Operative techniques for lung volume reduction surgery.

Chest surgery clinics of North America·2003
Same journal

Lung transplantation for emphysema.

Chest surgery clinics of North America·2003
See all related articles

Lung volume reduction surgery (LVRS) is a viable option for select patients with symptomatic emphysema. Recent studies offer realistic outcomes and selection criteria, with cost-benefit data available for advanced emphysema cases.

Area of Science:

  • Pulmonary Medicine
  • Thoracic Surgery
  • Health Economics

Background:

  • Symptomatic emphysema significantly impacts patient quality of life.
  • Lung Volume Reduction Surgery (LVRS) is a potential treatment for severe emphysema.
  • Objective data on LVRS outcomes and cost-effectiveness are crucial for clinical decision-making.

Purpose of the Study:

  • To evaluate the outcomes and cost-effectiveness of LVRS in patients with symptomatic emphysema.
  • To present a validated algorithm for selecting optimal candidates for LVRS.
  • To analyze the costs and benefits of LVRS using data from the National Emphysema Treatment Trial (NETT).

Main Methods:

  • Review of controlled studies on LVRS outcomes.
  • Development and validation of a patient selection algorithm.

Related Experiment Videos

  • Analysis of cost data collected simultaneously with clinical outcomes in the NETT.

    • Main Results:

    • LVRS is a valid surgical option for a carefully selected group of patients with symptomatic emphysema.
    • A validated algorithm now exists for identifying optimal candidates for LVRS.
    • NETT data provide a unique perspective on the costs and benefits of LVRS in advanced emphysema.

    Conclusions:

    • LVRS is a beneficial intervention for a specific subset of patients with emphysema.
    • The validated selection algorithm enhances the precision of patient candidacy for LVRS.
    • Ongoing data collection is essential to fully understand the long-term advantages of LVRS for Chronic Obstructive Pulmonary Disease (COPD).